VenatoRx Pharmaceuticals, Inc. SBIR Phase I Award, March 2017

A SBIR Phase I contract was awarded to VenatoRx Pharmaceuticals in March, 2017 for $599,998.0 USD from the U.S. Department of Health & Human Services.

Overview Structured Data Issues Contributors Activity

sbir.gov/node/1246461

Is a

SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient

VenatoRx Pharmaceuticals

Government Agency

Award Type

SBIR0

Contract Number (US Government)

1R43AI129009-010

Award Phase

Phase I0

Award Amount (USD)

599,9980

Date Awarded

March 15, 2017

End Date

February 28, 2019

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like VenatoRx Pharmaceuticals, Inc. SBIR Phase I Award, March 2017

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API